BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35942277)

  • 1. Clinical Features in Parkinson's Disease Patients with Hyperechogenicity in Substantia Nigra: A Cross-Sectional Study.
    Zhu S; Wang Y; Jiang Y; Gu R; Zhong M; Jiang X; Shen B; Zhu J; Yan J; Pan Y; Zhang L
    Neuropsychiatr Dis Treat; 2022; 18():1593-1601. PubMed ID: 35942277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson's Disease in Xinjiang.
    Wei R; Zhang Y; Li P; Xu Z; Zhang L; He Y; Wu Q; Shi Y; Yuan Y; Aisha A
    Parkinsons Dis; 2023; 2023():8867546. PubMed ID: 37304832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.
    Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
    Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson's Disease.
    Zhang S; Tao K; Wang J; Duan Y; Wang B; Liu X
    Front Cell Neurosci; 2020; 14():216. PubMed ID: 32848616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substantia nigra hyperechogenicity does not correlate with motor features in Parkinson's disease.
    Jesus-Ribeiro J; Sargento-Freitas J; Sousa M; Silva F; Freire A; Januário C
    J Neurol Sci; 2016 May; 364():9-11. PubMed ID: 27084206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study.
    Yu SY; Cao CJ; Zuo LJ; Chen ZJ; Lian TH; Wang F; Hu Y; Piao YS; Li LX; Guo P; Liu L; Yu QJ; Wang RD; Chan P; Chen SD; Wang XM; Zhang W
    BMC Neurol; 2018 Jan; 18(1):9. PubMed ID: 29343241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.
    Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Tan YY; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Chen SD
    J Parkinsons Dis; 2018; 8(2):333-340. PubMed ID: 29614699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson's disease: a Chinese population-based study.
    Li T; Shi J; Qin B; Fan D; Liu N; Ni J; Zhang T; Zhou H; Xu X; Wei M; Zhang X; Wang X; Liu J; Wang Y; Tian J
    Neurol Sci; 2020 Mar; 41(3):661-667. PubMed ID: 31754876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation Between Substantia Nigra Hyperechogenicity and Iron Metabolism in the Postural Instability Gait Difficulty Subtype of Parkinson's Disease.
    Ying CC; Wang CS; Ren YK; Ding CW; Zhang YC; Wu J; Yang M; Zhang Y; Mao P; Sheng YJ; Chen XF; Mao CJ; Liu CF
    Ultrasound Med Biol; 2023 Nov; 49(11):2422-2427. PubMed ID: 37666708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Asymmetry of Substantia Nigra Hyperechogenicity and Clinical Characteristics in Different Parkinson Disease Subtypes: A 5-Year Follow-up Study.
    Fu XY; Zhang YC; Ding CW; Zhao P; Liu QY; Yang M; Wang CS; Chen XF; Zhang Y; Sheng YJ; Mao P; Mao CJ; Liu CF
    Ultrasound Med Biol; 2022 Oct; 48(10):2139-2145. PubMed ID: 35953347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.
    Toomsoo T; Liepelt-Scarfone I; Berg D; Kerner R; Pool AH; Kadastik-Eerme L; Rubanovits I; Asser T; Taba P
    Ultrasound Med Biol; 2019 Jan; 45(1):122-128. PubMed ID: 30482710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
    Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
    Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantia nigra hyperechogenicity in Polish patients with Parkinson's disease.
    Ambrosius W; Michalak S; Owecki M; Łukasik M; Florczak-Wyspiańska J; Kozubski W
    Folia Morphol (Warsz); 2014 Aug; 73(3):267-71. PubMed ID: 25706660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of substantia nigra hyperechogenicity to risk of Lewy body disease in idiopathic REM sleep behavior disorder patients: a longitudinal study.
    Miyamoto M; Miyamoto T
    Sleep Med; 2020 Apr; 68():31-34. PubMed ID: 32018190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gait Analysis with Wearables Is a Potential Progression Marker in Parkinson's Disease.
    Zhu S; Wu Z; Wang Y; Jiang Y; Gu R; Zhong M; Jiang X; Shen B; Zhu J; Yan J; Pan Y; Zhang L
    Brain Sci; 2022 Sep; 12(9):. PubMed ID: 36138949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency.
    Hoeppner J; Prudente-Morrissey L; Herpertz SC; Benecke R; Walter U
    Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):92-7. PubMed ID: 18806917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the substantia nigra echogenicity and
    Mašková J; Školoudík D; Štofaniková P; Ibarburu V; Kemlink D; Zogala D; Trnka J; Krupička R; Šonka K; Růžička E; Dušek P
    Sleep Med; 2020 Jun; 70():116-123. PubMed ID: 32403038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron accumulation and microglia activation contribute to substantia nigra hyperechogenicity in the 6-OHDA-induced rat model of Parkinson's disease.
    Zhu Y; Wang B; Tao K; Yang H; Wang Y; Zhou T; Yang Y; Yuan L; Liu X; Duan Y
    Parkinsonism Relat Disord; 2017 Mar; 36():76-82. PubMed ID: 28108264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.